A multi-kinase inhibitor APG-2449 enhances the antitumor effect of Ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition

Qiuyun Luo(Sun Yat-sen University), Dajun Yang(Sun Yat-sen University)

Research Square

July 6, 2020

10.21203/rs.3.rs-39993/v1

Cited by 0

Related Papers

Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma

|Cancer Medicine|2020|49